Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

ALS Causative Mutations in KIF5A Disrupt Autoinhibition Leading to Toxic Gain of Function

Cilnidipine, a Novel N-Type Specific Calcium Channel Antagonist, Has Potent Activity at the Nav1.7 Sodium Channel, Which May Have Implications for Treatment of Certain Neuropathic Pain Conditions

Author:Sternlicht, Andrew   

Session Name:S23: Pain  

Topic:Pain  

Program Number:S23.003  

Author Institution:Aisa Pharma, Inc., Boston, MA  

Postherpetic pruritus successfully treated with Onabotulinum toxin: A case report

Concentration QT Interval Modeling of Intranasally Administered Zavegepant in Healthy Subjects